david miklos, md, phd, explains how ibrutinib is being studied for the treatment of gvhd
Published 6 years ago • 45 plays • Length 1:51
Download video MP4
Download video MP3
Similar videos
-
1:44
david miklos, md, phd, describes the optimal way to use ibrutinib in the treatment of gvhd
-
9:28
david miklos, md, phd: ibrutinib in chronic graft-versus-host disease
-
3:27
david miklos, md, discusses the outcomes in the phase 2 ibrutinib study for chronic gvhd
-
13:34
allogeneic transplants & graft-versus-host disease (gvhd) | dr. david miklos, stanford
-
7:27
ibrutinib to treat chronic graft versus host disease
-
51:29
„az vagy, amit megeszel”-"azért mentem az orvosi egyetemre, mert azt ígérték, ott lehet gyógyítani."
-
1:02:02
heart failure i: evaluating myocardial viability (zoghbi, mahmarian, shah) january 23, 2018
-
31:43
methotrexate: myths and realities
-
4:41
despite toxicities, ibrutinib is beneficial for treatment-resistant graft-vs.-host disease
-
21:21
clinical impact of h-y alloimmunization by david miklos, md, phd
-
1:09
david miklos, md, on developing an orphan drug for a small population of patients
-
23:44
mechanisms of disease: biologic pipeline for ibd
-
18:03
understanding the contraindications to the use of immunomodulators and biologics for ibd
-
29:46
case discussion: when and how to modify ibd therapies
-
24:37
current management of myelofibrosis - ronald hoffman, md
-
1:59
david j. mcconkey, phd, discusses how genomics helps us understand heterogeneity in bladder cancer
-
1:07
double oncogenic hits of 17p13(del) and 1q21(amp) in myeloma
-
2:37
the epigenomics of myeloma
-
20:34
overview (myung h. park, md) march 9-10, 2017
-
1:39
robert soiffer, md, discusses ways to enhance the activity of il-2 in chronic gvhd
-
0:48
myeloma prognosis - the emergence of mrd
-
46:12
a new immunometabolic perspective of intervertebral disc degeneration - vera francisco
Clip.africa.com - Privacy-policy